Imagine: Ecological stoves safeguard family health in Mexico
With Fondo Para la Paz, we’ve developed ecological stoves for safer indoor cooking, enhancing respiratory health for rural Mexican families
Search
VSV-GP
VSV-GP
C3-binding polypeptide
C3-binding polypeptide
Modified yersinia
Modified yersinia
KISIMA® cancer vaccine
KISIMA® Cancer Vaccine
IL11 antibody
IL11 antibody
DLL3/CD3 T-cell engager
DLL3/CD3 T-cell engager
GLP-1/FGF21 agonist
GLP-1/FGF21 agonist
Our Partners Bioharmony
Chandra Ghose, Founder and CEO of Bioharmony Therapeutics, talks about the urgent need for developing new antimicrobials and the benefits of partnering with Boehringer Ingelheim.
SIRPα antagonist
SIRPα antagonist
CD137/FAP agonist
CD137/FAP agonist
BI 1358894
BI 1358894
B7-H6/CD3 T-Cell Engager
B7-H6/CD3 T-Cell Engager
Access to Healthcare Strategy Sustainable Access Models
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering more health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Digital Therapeutic
Digital Therapeutic
BI 764198
BI 764198: TRPC6 inhibitor
KRAS multi-inhibitor
KRAS multi-inhibitor
NPY2r agonist
Food intake regulator
LastMile increases access to veterinary care in Africa
Boehringer Ingelheim’s LastMile initiative reaches over 40,000 smallholder farmers in Sub-Saharan Africa increasing access to veterinary medicine
BI Access to Healthcare Strategy_Availability
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Access to Healthcare Strategy Innovation
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
BI 765845
Heart disease modulator
Survodutide (BI 456906)
Survodutide (BI 456906)
Making more health through animal health
Boehringer Ingelheim and Ashoka aim to build a world with a greater access to health for people, animals and their communities.
Our partners university of georgia
We're partnering with the University of Georgia to address unmet needs and find solutions to some of the biggest challenges in animal health.